pLXIN-Luc Citations (4)

Originally described in: PLXIN-Luciferase, stable expresses luciferase in mammalian cells by retrovirus system
Unpublished

---

Articles Citing pLXIN-Luc

Articles
Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junin Viruses. Borenstein-Katz A, Shulman A, Hamawi H, Leitner O, Diskin R. J Virol. 2019 Apr 3;93(8). pii: JVI.00090-19. doi: 10.1128/JVI.00090-19. Print 2019 Apr 15. PubMed
Variations in Core Packing of GP2 from Old World Mammarenaviruses in their Post-Fusion Conformations Affect Membrane-Fusion Efficiencies. Shulman A, Katz M, Cohen-Dvashi H, Greenblatt HM, Levy Y, Diskin R. J Mol Biol. 2019 May 17;431(11):2095-2111. doi: 10.1016/j.jmb.2019.04.012. Epub 2019 Apr 18. PubMed
Rational design of universal immunotherapy for TfR1-tropic arenaviruses. Cohen-Dvashi H, Amon R, Agans KN, Cross RW, Borenstein-Katz A, Mateo M, Baize S, Padler-Karavani V, Geisbert TW, Diskin R. Nat Commun. 2020 Jan 3;11(1):67. doi: 10.1038/s41467-019-13924-6. PubMed
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment. Choi S, Hong JA, Choi HJ, Song JJ. Mol Ther Oncolytics. 2022 Sep 17;27:26-47. doi: 10.1016/j.omto.2022.09.004. eCollection 2022 Dec 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.